Wolfe Research Upgrades Vera Therapeutics (VERA) to Outperform

March 10, 2026 5:36 PM

Wolfe Research analyst Andy Chen upgraded Vera Therapeutics (NASDAQ: VERA) from Peerperform to Outperform with a price target of $88.00.The ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found